139 related articles for article (PubMed ID: 25824751)
1. RASSF1A gene methylation is associated with nasopharyngeal carcinoma risk in Chinese.
Wu K; Xu XN; Chen Y; Pu XL; Wang BY; Tang XD
Asian Pac J Cancer Prev; 2015; 16(6):2283-7. PubMed ID: 25824751
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.
Ye M; Huang T; Ni C; Yang P; Chen S
EBioMedicine; 2017 Apr; 18():32-40. PubMed ID: 28396012
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the
Lao TD; Thieu HH; Nguyen DH; Le TAH
Int J Biol Markers; 2022 Mar; 37(1):31-39. PubMed ID: 34935528
[TBL] [Abstract][Full Text] [Related]
4. Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma.
Wang T; Liu H; Chen Y; Liu W; Yu J; Wu G
J Exp Clin Cancer Res; 2009 Dec; 28(1):160. PubMed ID: 20042089
[TBL] [Abstract][Full Text] [Related]
5. Association of RASSF1A promoter methylation with lung cancer risk: a meta-analysis.
Huang YZ; Wu W; Wu K; Xu XN; Tang WR
Asian Pac J Cancer Prev; 2014; 15(23):10325-8. PubMed ID: 25556469
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
Fendri A; Masmoudi A; Khabir A; Sellami-Boudawara T; Daoud J; Frikha M; Ghorbel A; Gargouri A; Mokdad-Gargouri R
Cancer Biol Ther; 2009 Mar; 8(5):444-51. PubMed ID: 19221469
[TBL] [Abstract][Full Text] [Related]
7. Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies.
Li YS; Xie Q; Yang DY; Zheng Y
Mol Biol Rep; 2014 Jun; 41(6):3925-33. PubMed ID: 24566681
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population.
Hutajulu SH; Indrasari SR; Indrawati LP; Harijadi A; Duin S; Haryana SM; Steenbergen RD; Greijer AE; Middeldorp JM
Mol Cancer; 2011 May; 10():48. PubMed ID: 21535891
[TBL] [Abstract][Full Text] [Related]
9. The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics.
Shao C; Dai W; Li H; Tang W; Jia S; Wu X; Luo Y
PLoS One; 2017; 12(2):e0171676. PubMed ID: 28207831
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Methylation of RASSF1A gene Contribute to the Risk of Renal Cell Carcinoma: a Meta-Analysis.
Yu GS; Lai CY; Xu Y; Bu CF; Su ZX
Asian Pac J Cancer Prev; 2015; 16(11):4665-9. PubMed ID: 26107221
[TBL] [Abstract][Full Text] [Related]
11. Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues.
Zhou L; Jiang W; Ren C; Yin Z; Feng X; Liu W; Tao Q; Yao K
Neoplasia; 2005 Sep; 7(9):809-15. PubMed ID: 16229803
[TBL] [Abstract][Full Text] [Related]
12. Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis.
Shi DT; Han M; Gao N; Tian W; Chen W
Tumour Biol; 2014 Feb; 35(2):943-8. PubMed ID: 23982879
[TBL] [Abstract][Full Text] [Related]
13. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
Lo KW; Kwong J; Hui AB; Chan SY; To KF; Chan AS; Chow LS; Teo PM; Johnson PJ; Huang DP
Cancer Res; 2001 May; 61(10):3877-81. PubMed ID: 11358799
[TBL] [Abstract][Full Text] [Related]
14. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP
Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
Yang X; Dai W; Kwong DL; Szeto CY; Wong EH; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lung ML
Int J Cancer; 2015 Feb; 136(4):E127-35. PubMed ID: 25196065
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation of RASSF1A gene may be correlated with colorectal carcinogenesis: a meta-analysis.
Wang HL; Zhang Y; Liu P; Zhou PY
Mol Biol Rep; 2014 Jun; 41(6):3991-9. PubMed ID: 24566684
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP
Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549
[TBL] [Abstract][Full Text] [Related]
18. Molecular alterations of the WWOX gene in nasopharyngeal carcinoma.
Yang Z; Lan H; Chen X; Li P; Li S; Mo W; Tang A
Neoplasma; 2014; 61(2):170-6. PubMed ID: 24299313
[TBL] [Abstract][Full Text] [Related]
19. Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification.
Ooft ML; van Ipenburg J; van Loo R; de Jong R; Moelans C; Braunius W; de Bree R; van Diest P; Koljenović S; Baatenburg de Jong R; Hardillo J; Willems SM
J Clin Pathol; 2018 Apr; 71(4):351-359. PubMed ID: 28893862
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; Wong AY; Huang DP
Oncol Rep; 2004 Oct; 12(4):781-7. PubMed ID: 15375500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
